$70.2MSeries C, 10 September 2025
Series C to fund the Phase 3 trial of denovoSkin and industrialise its production platform.
- Amount
- $70.2M
- Stage
- Series C
- Announced
- 10 September 2025
- Lead
- Giammaria Giuliani family office
- Other investors
- Shiloh Advisors AG, Rode Kruis Ziekenhuis, Swisspreneur investor collective
- Use of funds
- Series C to fund the Phase 3 trial of denovoSkin and industrialise its production platform.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Cutiss raises €58M (Series C) - Tech.eu Funding Explorer tech.eu
Cutiss raises €58M (Series C) - Tech.eu Funding Explorer funding.tech.eu